Stay updated with breaking news from Ridge Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
15 June 2023 NORTHERN 3 VCT PLC ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2023 Northern 3 VCT PLC is a Venture Capital Trust managed by Mercia Fund Management Limited. It invests... | June 15, 2023
15 JUNE 2023 NORTHERN VENTURE TRUST PLC ANNUAL FINANCIAL REPORT FOR THE PERIOD ENDED 31 MARCH 2023 Northern Venture Trust PLC is a Venture Capital Trust whose investment adviser is... | June 15, 2023
Investegate announcements from Northern Venture Tst, Annual Financial Report
Search jobs 01-Apr-2021 RDIF and TopRidge Pharma agree to produce over 100 million doses of the Sputnik V vaccine in China RDIF and Moscow, April 1, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and TopRidge Pharma (a subsidiary company of one of China’s pharmaceutical market leaders, Tibet Rhodiola Pharmaceutical Holding), have agreed to cooperate on production of over 100 million doses per year of the world’s first registered vaccine against coronavirus Sputnik V in China. This amount of the vaccine wil...
Russian Direct Investment Fund agrees to manufacture 100 mln doses of Sputnik V in China Sputnik V has been registered in 58 countries globally with total population of over 1.5 bln people © AFK Sistema Press Office/TASS MOSCOW, April 1. /TASS/. The Russian Direct Investment Fund (RDIF) and TopRidge Pharma have agreed to produce over 100 mln doses of Russia’s anti-coronavirus vaccine Sputnik V annually in China, the Fund said in a statement on Thursday. Read also "The Russian Direct Investment Fund and TopRidge Pharma (a subsidiary company of one of China’s pharmaceutical market leader...